Castle Biosciences, Inc. (CSTL) Financials
CSTL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 561.2 million | 91.1 million |
| March 31, 2026 | 547.8 million | 86.4 million |
| Dec. 31, 2025 | 578.6 million | 107.7 million |
| Sept. 30, 2025 | 562.8 million | 95.7 million |
CSTL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 6.6 million | 11.6 million |
| March 31, 2026 | -34.6 million | 9.8 million |
| Dec. 31, 2025 | 19.7 million | 11.4 million |
| Sept. 30, 2025 | 7.8 million | 12.1 million |
CSTL Net Income
No data available :(
CSTL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 266.8 million | 7.2 million | 26.6 million |
| March 31, 2026 | 261.7 million | 8.4 million | 26.7 million |
| Dec. 31, 2025 | 299.5 million | 9.6 million | 26.9 million |
| Sept. 30, 2025 | 287.5 million | 10.0 million | 27.1 million |
CSTL Shares Outstanding
CSTL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 8.7 million | 14.5 million | 66.1 million | 40.9 million |
| March 31, 2026 | 12.5 million | 14.4 million | 64.9 million | 41.0 million |
| Dec. 31, 2025 | 7.2 million | 13.5 million | 56.7 million | 33.4 million |
| Sept. 30, 2025 | 14.8 million | 13.0 million | 55.9 million | 32.8 million |
CSTL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 103.5 million | 23.7 million |
| March 31, 2026 | 83.7 million | 20.5 million |
| Dec. 31, 2025 | 87.0 million | 18.3 million |
| Sept. 30, 2025 | 83.0 million | 18.7 million |
CSTL Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CSTL
Price: $32.91
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 126500
Market Capitalization: 952.5 million